Pages that link to "Template:DocumentData"

The following pages link to Template:DocumentData:

Displaying 50 items.

• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 2 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 24 (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40b-002 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (1) - (5) (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 3 (6) - (11) (transclusion) (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (e) (transclusion) (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (f) (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - Sponsor-Investigator (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 (b) - CRO (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.50 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.52 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (transclusion) (← links)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 list of investigators (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (n) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (o) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.40 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.45 (transclusion) (← links)
• Reference:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI C. (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Investigator (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2 (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Sub-Investigator (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - investigator (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - principal investigator (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4 (transclusion) (← links)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.2 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.2 (transclusion) (← links)
• Reference:N.A. Article from Mora et al. 2023 - (transclusion) (← links)
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 25 (transclusion) (← links)
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 30-001 (transclusion) (← links)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigator (transclusion) (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (d) (transclusion) (← links)
• Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (h) (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.3 - Investigator (transclusion) (← links)
• Reference:USA 21 CFR Part 54 09-Apr-2025 § 54.4 disclosure (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.53 (c) (vi) (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.60-001 (transclusion) (← links)
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.64-001 (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (e) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.3 (i) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.43 (c) (4) (transclusion) (← links)
• Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart E (transclusion) (← links)
• Reference:ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.3 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.1 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.6 (transclusion) (← links)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 6.1 (transclusion) (← links)
• Reference:EU EMA/INS/GCP/126568/2023 - Annual Report of the Good Clinical Practice (GCP) Inspectors' Working Group (IWG) 2022 2023 3.1.2 - Organisation (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 49 (transclusion) (← links)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 47-002 (transclusion) (← links)